2018
DOI: 10.3389/fcvm.2018.00027
|View full text |Cite
|
Sign up to set email alerts
|

Cell Phenotype Transitions in Cardiovascular Calcification

Abstract: Cardiovascular calcification was originally considered a passive, degenerative process, however with the advance of cellular and molecular biology techniques it is now appreciated that ectopic calcification is an active biological process. Vascular calcification is the most common form of ectopic calcification, and aging as well as specific disease states such as atherosclerosis, diabetes, and genetic mutations, exhibit this pathology. In the vessels and valves, endothelial cells, smooth muscle cells, and fibr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
55
0
4

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(61 citation statements)
references
References 114 publications
2
55
0
4
Order By: Relevance
“…Furthermore, cardiac calcification at the mitral annulus is a process possessing characteristics of both atherosclerotic plaque calcification and media calcification [ 13 ]. In general, the process of arterial calcification has three important pathological characteristics (i) loss of circulating calcification inhibitors (i.e., pyrophosphate (PP i ), (vitamin K-dependent) carboxylated matrix gla protein and fetuin-A) [ 14 , 15 ], (ii) gain of circulating calcification stimulators (i.e., hyperphosphatemia, hypercalcemia and uremic toxins) [ 15 , 16 ] and (iii) the ability of vascular cells, i.e., vascular smooth muscle cells (VSMCs) in the (medial or intimal) arterial wall or valve interstitial cells (VICs) in aortic valves, to transdifferentiate into bone-like cells which goes along with upregulation of osteo/chondrogenic marker genes such as Runt-related transcription factor 2 (Runx2), tissue non-specific alkaline phosphatase (TNAP), Bone morphogenetic protein 2 (BMP2) and SRY-Box transcription factor 9 (Sox9). These bone-like cells produce and release calcified matrix vesicles, in which calcium and phosphate is built up, into the extracellular matrix resulting into mineralization of the surrounding tissue [ 15 , 16 ].…”
Section: Arterial Calcificationmentioning
confidence: 99%
“…Furthermore, cardiac calcification at the mitral annulus is a process possessing characteristics of both atherosclerotic plaque calcification and media calcification [ 13 ]. In general, the process of arterial calcification has three important pathological characteristics (i) loss of circulating calcification inhibitors (i.e., pyrophosphate (PP i ), (vitamin K-dependent) carboxylated matrix gla protein and fetuin-A) [ 14 , 15 ], (ii) gain of circulating calcification stimulators (i.e., hyperphosphatemia, hypercalcemia and uremic toxins) [ 15 , 16 ] and (iii) the ability of vascular cells, i.e., vascular smooth muscle cells (VSMCs) in the (medial or intimal) arterial wall or valve interstitial cells (VICs) in aortic valves, to transdifferentiate into bone-like cells which goes along with upregulation of osteo/chondrogenic marker genes such as Runt-related transcription factor 2 (Runx2), tissue non-specific alkaline phosphatase (TNAP), Bone morphogenetic protein 2 (BMP2) and SRY-Box transcription factor 9 (Sox9). These bone-like cells produce and release calcified matrix vesicles, in which calcium and phosphate is built up, into the extracellular matrix resulting into mineralization of the surrounding tissue [ 15 , 16 ].…”
Section: Arterial Calcificationmentioning
confidence: 99%
“…Впрочем, в толще матрикса могут встречаться единичные клетки, ко-экспрессирующие эндотелиальные и мезенхимальные маркеры, например, CD31 и α-SMA [9]. Природа этого явления не до конца понятна, предполагается, что оно может быть связано с эндотелиально-мезенхимальной трансформацией ЭК [9][10][11].…”
Section: Financial Disclosureunclassified
“…Molecular vascular calcification mechanisms are a complex intersection of regulatory pathways, including adenosine signaling, osteochondrogenesis, inflammation, endocrine pathways, hypoxia, malnutrition, autophagy, phosphate transport, and phosphate signaling. Please see these recent reviews for current detail on cardiovascular calcification mechanisms (Wu et al, 2013 ; Hortells et al, 2018 ; Zazzeroni et al, 2018 ).…”
Section: Calcific Potential Of the Placentamentioning
confidence: 99%